BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Summary of revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue
Total	$ 1,700,320	$ 431,516	$ 5,988,003	$ 1,617,508
Research and development services (over-time)
Disaggregation of Revenue
Total	197,812	343,624	586,285	996,597
Equipment lease services (over-time)
Disaggregation of Revenue
Total	43,960	0	150,048
Clinical laboratory testing services (point-in-time)
Disaggregation of Revenue
Total	826,613	0	3,154,263
Supply chain
Disaggregation of Revenue
Total	23,947	4,358	123,947	35,678
Asset marking
Disaggregation of Revenue
Total	113,721	83,534	386,160	303,261
Large scale DNA production
Disaggregation of Revenue
Total	0	0		$ 281,972
Diagnostic kits
Disaggregation of Revenue
Total	$ 494,267	$ 0	$ 1,587,300